Artificial Intelligence Algorithms for Discovering New Active Compounds Targeting TRPA1 Pain Receptors
Open Access
Abstract
Transient receptor potential ankyrin 1 (TRPA1) is a ligand-gated calcium channel activated by cold temperatures and by a plethora of electrophilic environmental irritants (allicin, acrolein, mustard-oil) and endogenously oxidized lipids (15-deoxy-∆12, 14-prostaglandin J2 and 5, 6-eposyeicosatrienoic acid). These oxidized lipids work as agonists, making TRPA1 a key player in inflammatory and neuropathic pain. TRPA1 antagonists acting as non-central pain blockers are a promising choice for future treatment of pain-related conditions having advantages over current therapeutic choices A large variety of in silico methods have been used in drug design to speed up the development of new active compounds such as molecular docking, quantitative structure-activity relationship models (QSAR), and machine learning classification algorithms. Artificial intelligence methods can significantly improve the drug discovery process and it is an attractive field that can bring together computer scientists and experts in drug development. In our paper, we aimed to develop three machine learning algorithms frequently used in drug discovery research: feedforward neural networks (FFNN), random forests (RF), and support vector machines (SVM), for discovering novel TRPA1 antagonists. All three machine learning methods used the same class of independent variables (multilevel neighborhoods of atoms descriptors) as prediction of activity spectra for substances (PASS) software. The model with the highest accuracy and most optimal performance metrics was the random forest algorithm, showing 99% accuracy and 0.9936 ROC AUC. Thus, our study emphasized that simpler and robust machine learning algorithms such as random forests perform better in correctly classifying TRPA1 antagonists since the dimension of the dependent variables dataset is relatively modest.Keywords
This publication has 35 references indexed in Scilit:
- TRPA1 Antagonists for Pain ReliefPharmaceuticals, 2018
- Human TRPA1 is a heat sensor displaying intrinsic U-shaped thermosensitivityScientific Reports, 2016
- TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stressBrain, 2016
- TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute goutFree Radical Biology and Medicine, 2014
- 5,6-EET Is Released upon Neuronal Activity and Induces Mechanical Pain Hypersensitivity via TRPA1 on Central Afferent TerminalsThe Journal of Neuroscience, 2012
- Emerging drug targets for pain treatmentEuropean Journal of Pharmacology, 2012
- TRPA1: The Central Molecule for Chemical Sensing in Pain Pathway?: Figure 1.Journal of Neuroscience, 2008
- Cutaneous Nociception Evoked by 15-delta PGJ2 via Activation of Ion Channel TRPA1Molecular Pain, 2008
- TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic AgentsCell, 2006
- TRP ion channels in the nervous systemCurrent Opinion in Neurobiology, 2004